Simon Quick Advisors’s CorMedix CRMD Stock Holding History

Simon Quick Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-400	Closed	-$2K	–	226
2022 Q1	$2K	Hold	400	–	–	﹤0.01%	333
2021 Q4	$2K	Hold	400	–	–	﹤0.01%	351
2021 Q3	$1K	Hold	400	–	–	﹤0.01%	405
2021 Q2	$2K	Hold	400	–	–	﹤0.01%	420
2021 Q1	$3K	Hold	400	–	–	﹤0.01%	426
2020 Q4	$3K	Hold	400	–	–	﹤0.01%	410
2020 Q3	$2K	Hold	400	–	–	﹤0.01%	402
2020 Q2	$3K	Hold	400	–	–	﹤0.01%	384
2020 Q1	$1K	Hold	400	–	–	﹤0.01%	441
2019 Q4	$3K	Hold	400	–	–	﹤0.01%	538
2019 Q3	$3K	Hold	400	–	–	﹤0.01%	332
2019 Q2	$3.59K	Sell	400 -2,000	-83%	-$15.7K	﹤0.01%	305
2019 Q1	$23K	Buy	2,400 +2,000	+500%	+$18K	0.01%	294
2018 Q4	$3K	Hold	400	–	–	﹤0.01%	302
2018 Q3	$2K	Hold	400	–	–	﹤0.01%	286
2018 Q2	$0	Buy	+400	New	+$463	﹤0.01%	352
2018 Q1	–	Sell	-400	Closed	-$1K	–	335
2017 Q4	$1K	Hold	400	–	–	﹤0.01%	423
2017 Q3	$1K	Hold	400	–	–	﹤0.01%	497
2017 Q2	$1K	Hold	400	–	–	﹤0.01%	285
2017 Q1	$3K	Hold	400	–	–	﹤0.01%	300
2016 Q4	$3K	Buy	+400	New	+$4.05K	﹤0.01%	215

Other funds holding CRMD

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Simon Quick Advisors's CRMD Position: Q2 2022 in Review

Simon Quick Advisors sold out of CorMedix (CRMD) in Q2 2022, closing a stake of 400 shares — an estimated $2K sold.

Simon Quick Advisors first reported a position in CRMD in Q4 2016 and held it in 21 quarters. The position peaked at $23K in Q1 2019. 74 funds tracked by Wall St. Rank hold CRMD as of Q2 2022.

Simon Quick Advisors reported no remaining CorMedix position as of Q2 2022 after selling out during the quarter.
Simon Quick Advisors sold 400 CorMedix shares in Q2 2022, an estimated $2K.
Simon Quick Advisors first reported a position in CorMedix in Q4 2016 and held it in 21 quarters.
Simon Quick Advisors's CorMedix position peaked at $23K in Q1 2019.
74 funds tracked by Wall St. Rank held CorMedix as of Q2 2022.

Based on Simon Quick Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.